Skip to content

The effect of traditional chinese medicine on Pre-RC in advanced triple-negative breast cancer and its correlation with survival

The effect of traditional chinese medicine on Pre-RC in advanced triple-negative breast cancer and its correlation with survival

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-17011078
Enrollment
Unknown
Registered
2017-04-06
Start date
2017-04-10
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Triple-negative Breast Cancer

Interventions

experiment group: traditional chinese medicine

Sponsors

Guang'anmen Hospital,China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Female aged 10 to 70 years; 2. TNBC patients confirmed by pathological diagnosis and immunohistological examination; 3. TNBC with Stage IV; 4. patients with at least one tumor foci can be measured; 5. KPS=60 scores,expected lifetime=3 months.

Exclusion criteria

Exclusion criteria: 1. Patients with uncontrolled cardiovascular and cerebrovascular disease, liver and kidney disease, hematological disorder, etc; 2. Patients who are undergoing radiation and chemotherapy after the recurrence or metastasis; 3. Patients with other malignant tumor; 4. Patients with a history of mental illness who can not cooperate; 5. Patients who are receiving other drug tests; 6. Patients who are allergies to the drugs of the research.

Design outcomes

Primary

MeasureTime frame
DNA pre-replicative complex;

Countries

China

Contacts

Public ContactWenping Lu

Guang'anmen Hospital,China Academy of Chinese Medical Sciences

lu_wenping@sina.com+86 13811210423

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026